Verified employee & interview reviews

Alkem Laboratories Reviews

Mumbai, Maharashtra

—/ 5

0 reviews

Alkem Laboratories Limited is a leading Indian multinational pharmaceutical company headquartered in Mumbai, Maharashtra. Established on August 8, 1973, by co-founders Samprada Singh and Basudeo Narayan Singh, the company has grown over more than five decades into one of the largest generic and specialty pharmaceutical firms in India. Consistently ranked among the top ten companies in the Indian Pharmaceutical Market (IPM), Alkem holds a prominent position, particularly in acute therapeutic segments such as anti-infectives and gastroenterology, alongside a expanding presence in chronic therapies. The company engages comprehensively in the research, development, manufacturing, marketing, and sale of pharmaceutical formulations, branded generics, generic drugs, active pharmaceutical ingredients (APIs), biosimilars, and nutraceutical products. Its extensive therapeutic portfolio covers diverse medical areas, including anti-infective, gastroenterology, pain and analgesics, diabetology, cardiology, central nervous system, dermatology, gynecology, respiratory, oncology, and urology. Alkem's consumer healthcare portfolio also features prominent over-the-counter brands, health supplements, and diagnostics, with household names like Clavam, Pan, Pan-D, and Taxim-O ranking among the top pharmaceutical brands in India. Operationally, Alkem features a robust global infrastructure comprising 19 manufacturing facilities in India and 2 in the United States. Many of these state-of-the-art facilities are accredited by global regulatory authorities, including the US FDA, UK MHRA, and Australia's TGA. Alkem's research and development capabilities are anchored by multiple global R&D centers staffed by over 500 scientists focused on formulation development, abbreviated new drug applications (ANDAs), and advanced biologics. Through its subsidiary Enzene Biosciences, the company has made significant advancements in the biosimilar space and has recently expanded into the medical technology sector. Alkem possesses a formidable global footprint spanning over 40 countries, with key international markets located in the United States, Europe, Latin America, and various emerging economies. In the domestic market, Alkem Generics commands a leading position within the trade generics segment. The organization is supported by a large workforce of over 23,000 employees globally. Financially, Alkem Laboratories is a publicly traded company listed on both the National Stock Exchange (NSE) and the Bombay Stock Exchange (BSE) under the ticker ALKEM. For the fiscal year ending March 31, 2025, the company reported a consolidated revenue from operations of INR 12,964 crore (approximately USD 1.4 billion) and a net income of INR 2,165 crore. The company is currently led by Executive Chairman Basudeo N. Singh, Chief Executive Officer Dr. Vikas Gupta, and Managing Director Sandeep Singh. Alkem prioritizes corporate social responsibility and sustainability, actively executing community initiatives in education, healthcare, and rural development through the Alkem Foundation.